低剂量CT筛查对高风险参与者戒烟的影响:英国肺癌筛查试验结果
英国肺癌筛查试点试验将50-75岁高风险个体随机分为CT筛查组和常规护理对照组,发现筛查组在T1(基线扫描后2周)和T2(招募后至多2年)的戒烟率均显著高于对照组,且需要进一步临床检查者长期戒烟可能性更高。
要点
- CT筛查组T1戒烟率14% vs 对照组8%,T2为24% vs 21%。
- ITT分析显示筛查组戒烟几率显著更高:T1 aOR 2.38,T2 aOR 1.60。
- 需要额外临床检查者长期戒烟aOR 2.29,阴性结果者aOR 2.43。
核心结论
- CT肺癌筛查为高风险参与者提供了戒烟的教机,尤其在收到阳性扫描结果者中。
研究设计与样本
- 英国肺癌筛查试点试验,将50-75岁完成基线问卷的高风险个体随机分为CT筛查组或常规护理对照组。
- 共4055人随机,其中基线吸烟者1546人(干预组759人,对照组787人)。
- 吸烟状态通过自我报告确定,在T1(基线扫描结果或对照分配后2周)和T2(招募后至多2年)评估戒烟情况。
- 采用意向性治疗(ITT)回归分析,调整基线肺癌痛苦、试验站点和社会人口学变量。
主要发现
- T1戒烟率:对照组8%(36/479),干预组14%(75/527)。
- T2戒烟率:对照组21%(79/377),干预组24%(115/488)。
- ITT分析显示筛查组戒烟几率显著更高:T1 aOR 2.38(95%CI 1.56-3.64,p<0.001),T2 aOR 1.60(95%CI 1.17-2.18,p=0.003)。
- 需要额外临床检查的干预组参与者长期戒烟aOR 2.29(95%CI 1.62-3.22,p=0.007)。
- 收到阴性结果的干预组参与者长期戒烟aOR 2.43(95%CI 1.54-3.84,p<0.001)。
临床怎么用
- 在高风险人群肺癌筛查中应整合戒烟干预,利用筛查作为戒烟教机。
- 对需要额外临床检查或收到阴性结果者均应强化戒烟支持。
局限性
- 需要进一步行为学研究评估将戒烟干预与分层肺癌筛查整合的最佳策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking cessation was examined among high-risk participants in the UK Lung Cancer Screening (UKLS) Pilot Trial of low-dose CT screening. METHODS: High-risk individuals aged 50-75 years who completed baseline questionnaires were randomised to CT screening (intervention) or usual care (no screening control). Smoking habit was determined at baseline using self-report. Smokers were asked whether they had quit smoking since joining UKLS at T1 (2 weeks after baseline scan results or control assignment) and T2 (up to 2 years after recruitment). Intention-to-treat (ITT) regression analyses were undertaken, adjusting for baseline lung cancer distress, trial site and sociodemographic variables. RESULTS: Of a total 4055 individuals randomised to CT screening or control, 1546 were baseline smokers (759 intervention, 787 control). Smoking cessation rates were 8% (control n=36/479) versus 14% (intervention n=75/527) at T1 and 21% (control n=79/377) versus 24% (intervention n=115/488) at T2. ITT analyses indicated that the odds of quitting among screened participants were significantly higher at T1 (adjusted OR (aOR) 2.38, 95% CI 1.56 to 3.64, p<0.001) and T2 (aOR 1.60, 95% CI 1.17 to 2.18, p=0.003) compared with control. Intervention participants who needed additional clinical investigation were more likely to quit in the longer term compared with the control group (aOR 2.29, 95% CI 1.62 to 3.22, p=0.007) and those receiving a negative result (aOR 2.43, 95% CI 1.54 to 3.84, p<0.001). CONCLUSIONS: CT lung cancer screening for high-risk participants presents a teachable moment for smoking cessation, especially among those who receive a positive scan result. Further behavioural research is needed to evaluate optimal strategies for integrating smoking cessation intervention with stratified lung cancer screening. TRIAL REGISTRATION NUMBER: Results, ISRCTN 78513845.
引用
- Brain K, Carter B, Lifford KJ, et al. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. Thorax. 2017. PMID: 28710339. doi:10.1136/thoraxjnl-2016-209690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。